0

Journal Articles

in Statistics and Research Methods
 61-80 of 266 Articles
Original Contribution |  September 12, 2012 FREE
Spending Differences Associated With the Medicare Physician Group Practice Demonstration
Carrie H. Colla, PhD; David E. Wennberg, MD, MPH; Ellen Meara, PhD; et al.
JAMA. 2012;308(10):1015-1023. doi:10.1001/2012.jama.10812.
INCLUDES: , Supplemental Content
Medical News and Perspectives |  September 05, 2012
Critics of US House Proposal to Ax AHRQ Say Idea Is Penny-wise and Pound-foolish
Mike Mitka
JAMA. 2012;308(9):849-850. doi:10.1001/2012.jama.10500.
Viewpoint |  September 05, 2012
Clinical Trial Data as a Public Good
Marc A. Rodwin, JD, PhD; John D. Abramson, MD, MS
JAMA. 2012;308(9):871-872. doi:10.1001/jama.2012.9661.
Viewpoint |  August 22, 2012
Transforming Quality of Care and Improving Outcomes After Acute MI:  Lessons From the National Registry of Myocardial Infarction
William J. French, MD; Vanessa S. Reddy, MS; Hal V. Barron, MD
JAMA. 2012;308(8):771-772. doi:10.1001/jama.2012.9500.
Viewpoint |  August 22, 2012
The Value of Statistical Analysis Plans in Observational Research:  Defining High-Quality Research From the Start
Laine Thomas, PhD; Eric D. Peterson, MD, MPH
JAMA. 2012;308(8):773-774. doi:10.1001/jama.2012.9502.
Editorial |  August 15, 2012
Evolving Research on the Treatment of Health Effects of Violence and Human Rights Abuses:  From Observational Studies to Randomized Trials
Thomas B. Cole, MD, MPH; Annette Flanagin, RN, MA
JAMA. 2012;308(7):716-717. doi:10.1001/jama.2012.10078.
Medical News and Perspectives |  August 15, 2012
German Medical Group: Apology for Nazi Physicians’ Actions, Warning for Future
Edward H. Livingston, MD
JAMA. 2012;308(7):657-658. doi:10.1001/jama.2012.9649.
Medical News and Perspectives |  August 08, 2012
Groups Propose Plan to Accredit Controversial Stem Cell Therapy Clinics
Bridget M. Kuehn
JAMA. 2012;308(6):553-555. doi:10.1001/jama.2012.7959.
Viewpoint |  August 08, 2012
The Importance of Potential Studies That Have Not Existed and Registration of Observational Data Sets
John P. A. Ioannidis, MD, DSc
JAMA. 2012;308(6):575-576. doi:10.1001/jama.2012.8144.
Medical News and Perspectives |  June 20, 2012
IOM Urges FDA to Be More Aggressive in Monitoring Safety of Approved Drugs
Bridget M. Kuehn
JAMA. 2012;307(23):2475-2476. doi:10.1001/jama.2012.5993.
Viewpoint |  June 20, 2012
A Lifecycle Approach to the Evaluation of FDA Approval Methods and Regulatory Actions:  Opportunities Provided by a New IOM Report
Bruce M. Psaty, MD, PhD; Eric M. Meslin, PhD; Alasdair Breckenridge, MD, FRCP
JAMA. 2012;307(23):2491-2492. doi:10.1001/jama.2012.5545.
Viewpoint |  June 13, 2012
Adaptive Clinical Trials:  A Partial Remedy for the Therapeutic Misconception?
William J. Meurer, MD, MS; Roger J. Lewis, MD, PhD; Donald A. Berry, PhD
JAMA. 2012;307(22):2377-2378. doi:10.1001/jama.2012.4174.
Viewpoint |  June 13, 2012
Adaptive Trials in Clinical Research:  Scientific and Ethical Issues to Consider
Rieke van der Graaf, PhD; Kit C. B. Roes, PhD; Johannes J. M. van Delden, MD, PhD
JAMA. 2012;307(22):2379-2380. doi:10.1001/jama.2012.6380.
Editorial |  June 06, 2012
The JAMA Network Website:  Today's Content on the Future of Medical Publishing
Margaret A. Winker, MD; Matt Herron; Elizabeth Jones; et al.
JAMA. 2012;307(21):2321. doi:10.1001/jama.2012.5568.
Editorial |  April 18, 2012
Comparative Effectiveness Research:  Relative Successes
Robert M. Golub, MD; Phil B. Fontanarosa, MD, MBA
JAMA. 2012;307(15):1643-1645. doi:10.1001/jama.2012.490.
Editorial |  April 18, 2012
Is It Time for Medicine-Based Evidence?
John Concato, MD, MS, MPH
JAMA. 2012;307(15):1641-1643. doi:10.1001/jama.2012.482.
Medical News & Perspectives |  April 18, 2012
A Push for Comparative Effectiveness
Bridget M. Kuehn
JAMA. 2012;307(15):1570-1571. doi:10.1001/jama.2012.471.
Special Communication |  April 18, 2012
Methodological Standards and Patient-Centeredness in Comparative Effectiveness Research:  The PCORI Perspective
JAMA. 2012;307(15):1636-1640. doi:10.1001/jama.2012.466.
INCLUDES: CME
Viewpoint |  April 18, 2012
Addressing Low-Risk Comparative Effectiveness Research in Proposed Changes to US Federal Regulations Governing Research
Nancy Kass, ScD; Ruth Faden, PhD, MPH; Sean Tunis, MD, MSc
JAMA. 2012;307(15):1589-1590. doi:10.1001/jama.2012.491.
Viewpoint |  April 18, 2012
Continuous Patient Engagement in Comparative Effectiveness Research
C. Daniel Mullins, PhD; Abdulla M. Abdulhalim, BSPharm; Danielle C. Lavallee, PharmD, PhD
JAMA. 2012;307(15):1587-1588. doi:10.1001/jama.2012.442.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Pediatrics
Editorial  |  March 25, 2013
JAMA Pediatrics Hospital Medicine Theme Issue
Ron Keren, MD, MPH; Samir S. Shah, MD, MSCE
JAMA Pediatrics
Review Article  |  March 25, 2013
Influence of Surgeon Experience, Hospital Volume, and Specialty Designation on Outcomes in Pediatric Surgery:  A Systematic Review
Jarod P. McAteer, MD; Cabrini A. LaRiviere, MD, MPH; George T. Drugas, MD; et al.
JAMA Internal Medicine
Editorial  |  April 22, 2013
Trust in the Medical Literature—and Viewpoints in JAMA Internal Medicine
Robert Steinbrook, MD; Rita F. Redberg, MD, MSc
JAMA Internal Medicine
Viewpoint  |  April 22, 2013
Assessing Research Results in the Medical Literature:  Trust but Verify
Robert M. Califf, MD; Jonathan McCall, MS; Robert A. Harrington, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems